vs

Side-by-side financial comparison of Digimarc CORP (DMRC) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $8.9M, roughly 1.7× Digimarc CORP). On growth, Digimarc CORP posted the faster year-over-year revenue change (2.9% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs -5.3%).

Digimarc Corporation is a provider of enterprise software and services. The company's software, which includes digital identifiers, is designed to address counterfeiting, product authenticity, recycling accuracy, and supply chain traceability. Digimarc products are created for multiple industries such as apparel, consumer packaged goods, health and beauty, and automotive.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

DMRC vs IRIX — Head-to-Head

Bigger by revenue
IRIX
IRIX
1.7× larger
IRIX
$14.7M
$8.9M
DMRC
Growing faster (revenue YoY)
DMRC
DMRC
+72.6% gap
DMRC
2.9%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
-5.3%
DMRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DMRC
DMRC
IRIX
IRIX
Revenue
$8.9M
$14.7M
Net Profit
$-4.2M
Gross Margin
63.5%
37.2%
Operating Margin
-48.2%
Net Margin
-47.2%
Revenue YoY
2.9%
-69.7%
Net Profit YoY
51.4%
EPS (diluted)
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DMRC
DMRC
IRIX
IRIX
Q4 25
$8.9M
$14.7M
Q3 25
$7.6M
$12.5M
Q2 25
$8.0M
$13.6M
Q1 25
$9.4M
$11.9M
Q4 24
$8.7M
$12.7M
Q3 24
$9.4M
$11.6M
Q2 24
$10.4M
$12.6M
Q1 24
$9.9M
$11.8M
Net Profit
DMRC
DMRC
IRIX
IRIX
Q4 25
$-4.2M
Q3 25
$-8.2M
$-1.6M
Q2 25
$-8.2M
$-994.0K
Q1 25
$-11.7M
$-1.7M
Q4 24
$-8.6M
$-834.0K
Q3 24
$-10.8M
$-1.9M
Q2 24
$-9.3M
$-2.7M
Q1 24
$-10.3M
$-3.5M
Gross Margin
DMRC
DMRC
IRIX
IRIX
Q4 25
63.5%
37.2%
Q3 25
58.3%
32.1%
Q2 25
58.8%
34.5%
Q1 25
65.0%
42.5%
Q4 24
60.8%
44.0%
Q3 24
62.4%
37.3%
Q2 24
66.1%
40.7%
Q1 24
62.5%
37.9%
Operating Margin
DMRC
DMRC
IRIX
IRIX
Q4 25
-48.2%
Q3 25
-109.7%
-11.3%
Q2 25
-105.2%
-6.9%
Q1 25
-128.9%
-1.7%
Q4 24
-105.1%
-3.9%
Q3 24
-120.4%
-16.1%
Q2 24
-96.2%
-20.9%
Q1 24
-109.2%
-28.0%
Net Margin
DMRC
DMRC
IRIX
IRIX
Q4 25
-47.2%
Q3 25
-106.9%
-12.6%
Q2 25
-102.6%
-7.3%
Q1 25
-125.2%
-14.2%
Q4 24
-99.9%
-6.6%
Q3 24
-113.9%
-16.7%
Q2 24
-89.3%
-21.2%
Q1 24
-104.0%
-29.5%
EPS (diluted)
DMRC
DMRC
IRIX
IRIX
Q4 25
$-0.18
Q3 25
$-0.38
$-0.09
Q2 25
$-0.38
$-0.06
Q1 25
$-0.55
$-0.10
Q4 24
$-0.40
$-0.05
Q3 24
$-0.50
$-0.12
Q2 24
$-0.43
$-0.16
Q1 24
$-0.50
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DMRC
DMRC
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$12.9M
$6.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$40.2M
Total Assets
$53.0M
$29.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DMRC
DMRC
IRIX
IRIX
Q4 25
$12.9M
$6.0M
Q3 25
$12.6M
$5.6M
Q2 25
$16.1M
$6.8M
Q1 25
$21.6M
$7.2M
Q4 24
$28.7M
$2.4M
Q3 24
$33.7M
$3.9M
Q2 24
$41.5M
$4.1M
Q1 24
$48.9M
$5.4M
Total Debt
DMRC
DMRC
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
DMRC
DMRC
IRIX
IRIX
Q4 25
$40.2M
Q3 25
$41.4M
$4.7M
Q2 25
$46.5M
$6.1M
Q1 25
$50.0M
$852.0K
Q4 24
$61.4M
$2.1M
Q3 24
$70.2M
$2.6M
Q2 24
$77.2M
$4.2M
Q1 24
$84.5M
$6.5M
Total Assets
DMRC
DMRC
IRIX
IRIX
Q4 25
$53.0M
$29.2M
Q3 25
$55.4M
$28.4M
Q2 25
$60.7M
$31.6M
Q1 25
$66.5M
$34.2M
Q4 24
$75.8M
$29.1M
Q3 24
$85.0M
$30.2M
Q2 24
$93.4M
$31.2M
Q1 24
$99.7M
$34.1M
Debt / Equity
DMRC
DMRC
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DMRC
DMRC
IRIX
IRIX
Operating Cash FlowLast quarter
$991.0K
Free Cash FlowOCF − Capex
$895.0K
FCF MarginFCF / Revenue
10.0%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DMRC
DMRC
IRIX
IRIX
Q4 25
$991.0K
Q3 25
$-2.6M
$-1.2M
Q2 25
$-4.7M
$-397.0K
Q1 25
$-5.5M
$-1.1M
Q4 24
$-4.2M
$-1.2M
Q3 24
$-7.1M
$-3.1M
Q2 24
$-6.8M
$-1.3M
Q1 24
$-8.4M
$-1.6M
Free Cash Flow
DMRC
DMRC
IRIX
IRIX
Q4 25
$895.0K
Q3 25
$-2.8M
$-1.2M
Q2 25
$-4.9M
$-410.0K
Q1 25
$-5.5M
$-1.2M
Q4 24
$-4.2M
$-1.2M
Q3 24
$-7.2M
$-3.1M
Q2 24
$-6.9M
Q1 24
$-8.5M
$-1.7M
FCF Margin
DMRC
DMRC
IRIX
IRIX
Q4 25
10.0%
Q3 25
-36.9%
-9.4%
Q2 25
-61.0%
-3.0%
Q1 25
-59.1%
-9.8%
Q4 24
-49.1%
-9.8%
Q3 24
-75.7%
-26.5%
Q2 24
-66.1%
Q1 24
-85.8%
-14.0%
Capex Intensity
DMRC
DMRC
IRIX
IRIX
Q4 25
1.1%
Q3 25
2.9%
0.1%
Q2 25
2.5%
0.1%
Q1 25
0.6%
0.1%
Q4 24
0.2%
0.1%
Q3 24
0.7%
0.0%
Q2 24
0.3%
0.0%
Q1 24
1.1%
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DMRC
DMRC

Subscription$5.3M60%
The Government$3.6M41%

IRIX
IRIX

Segment breakdown not available.

Related Comparisons